Gemcitabine was not very effective towards both HCC cell lines (Supplementary Fig. 9c) which may be explained by its strong induction of RRM2 in the HCC cells (Supplementary Fig. 9b). The gene discussed is RRM2; the disease is hepatocellular carcinoma.